Trial Profile
Pegylated Somatropin in the Treatment of Children With Growth Hormone Deficient A Multicenter, Randomized, Open-label, Controlled Phase Ⅲ Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 10 Apr 2014 New trial record